Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
出版年份 2015 全文链接
标题
Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
作者
关键词
Antipsychotics, Therapeutic drug monitoring, CYP2D6, Genotyping
出版物
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 2, Pages 175-184
出版商
Springer Nature
发表日期
2015-10-30
DOI
10.1007/s00228-015-1965-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants
- (2015) Vincent Haufroid et al. CLINICAL TOXICOLOGY
- The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients
- (2015) Karen van der Weide et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CYP3A4*22is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
- (2015) Marina Venzon Antunes et al. PHARMACOGENOMICS
- Clinical applications of CYP genotyping in psychiatry
- (2014) Edoardo Spina et al. JOURNAL OF NEURAL TRANSMISSION
- High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography–tandem mass spectrometry
- (2013) Lisbeth Patteet et al. CLINICA CHIMICA ACTA
- Applications of CYP450 Testing in the Clinical Setting
- (2013) C. F. Samer et al. Molecular Diagnosis & Therapy
- Therapeutic Drug Monitoring of Common Antipsychotics
- (2012) Lisbeth Patteet et al. THERAPEUTIC DRUG MONITORING
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
- (2011) C. Hiemke et al. PHARMACOPSYCHIATRY
- Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
- (2010) Silvana Borges et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics and Psychoactive Drug Therapy: Ready for the Patient?
- (2010) Werner Steimer THERAPEUTIC DRUG MONITORING
- Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
- (2009) Magnhild Hendset et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
- (2008) Arzu Gunes et al. THERAPEUTIC DRUG MONITORING
- Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol
- (2003) Jae-Gook Shin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started